We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01690598
Recruitment Status : Completed
First Posted : September 24, 2012
Last Update Posted : June 10, 2015
Information provided by (Responsible Party):
Vejle Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2015
  Study Completion Date : February 2015